ameUpstreamDMPKASoligo SequenceCTT and 7 more items

Virginia Commonwealth University has awarded a contract to Integrated DNA Technologies Inc., effective October 6, 2026. The contract, identified as A236_P0359676, is valued at $181.00 and encompasses the procurement of synthetic oligonucleotide sequences for research applications. Delivery of all line items is designated to VCU Procurement in Virginia. The contract includes eight distinct oligonucleotide products representing upstream and downstream DMPKA (Drug Metabolism and Pharmacokinetics Assessment) sequences, along with indexed universal molecular identifier (i7 UMI) tagged sequences.

The awarded line items consist of various oligonucleotide sequences with unit prices ranging from $5.75 to $71.73 per sequence. These products include upstream DMPKA Soligo sequences, upstream rs374 single nucleotide polymorphism forward and reverse sequences, downstream DMPKA sequences with similar SNP designations, and i7 UMI-tagged sequences designated as rS73F and rS73R variants. Each line item is procured in a quantity of one unit, reflecting targeted research supply requirements for VCU's molecular research initiatives.